• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LXA4 通过抑制 METTL3 促进 M2 巨噬细胞极化从而增强前列腺癌的进展。

LXA4 enhances prostate cancer progression by facilitating M2 macrophage polarization via inhibition of METTL3.

机构信息

Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Wujin Road 85, Shanghai, 200080, China; Institute of Urology, Shanghai Jiao Tong University, Shanghai, 200080, China.

Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Wujin Road 85, Shanghai, 200080, China; Institute of Urology, Shanghai Jiao Tong University, Shanghai, 200080, China.

出版信息

Int Immunopharmacol. 2022 Jun;107:108586. doi: 10.1016/j.intimp.2022.108586. Epub 2022 Feb 25.

DOI:10.1016/j.intimp.2022.108586
PMID:35228032
Abstract

Tumor-associated macrophages (TAMs) are major innate immune cells that play crucial roles in prostate cancer onset and progression. Recently, increasing evidence has suggested that elevated N6-adenine methylation of mRNA is observed in prostate cancer tissues and is closely associated with a poor prognosis. However, its role in prostate cancer-associated macrophages remains poorly understood. Here, we showed that downregulation of METTL3 in prostate cancer TAMs modulated macrophages toward an M2-like phenotype and that this modulation was mediated by activation of STAT6. In addition, our data demonstrated that prostate cancer cell-derived small lipid molecule lipoxin A4 (LXA4) activated STAT6 by inhibiting METTL3. Treatment with PBP10 (an inhibitor of the LXA4 receptor) abolished the inhibition of METTL3 by LXA4 and consequently reduced the tumorigenicity of prostate cancer cells. Altogether, this work demonstrated that prostate cancer cells facilitate polarization of M2 like macrophages by releasing LXA4 via inhibiting METTL3. These findings provide new insight into the mechanism of microenvironmental regulation of macrophage polarization during prostate cancer progression.

摘要

肿瘤相关巨噬细胞(TAMs)是主要的先天免疫细胞,在前列腺癌的发生和发展中发挥着关键作用。最近,越来越多的证据表明,在前列腺癌组织中观察到 mRNA 的 N6-腺嘌呤甲基化水平升高,并且与预后不良密切相关。然而,其在前列腺癌相关巨噬细胞中的作用仍知之甚少。在这里,我们表明,下调前列腺癌 TAMs 中的 METTL3 可将巨噬细胞向 M2 样表型调节,这种调节是通过激活 STAT6 介导的。此外,我们的数据表明,前列腺癌细胞衍生的小分子脂质脂氧素 A4(LXA4)通过抑制 METTL3 来激活 STAT6。用 PBP10(LXA4 受体的抑制剂)处理可消除 LXA4 对 METTL3 的抑制作用,从而降低前列腺癌细胞的致瘤性。总之,这项工作表明,前列腺癌细胞通过释放 LXA4 抑制 METTL3 促进 M2 样巨噬细胞的极化。这些发现为前列腺癌进展过程中巨噬细胞极化的微环境调节机制提供了新的见解。

相似文献

1
LXA4 enhances prostate cancer progression by facilitating M2 macrophage polarization via inhibition of METTL3.LXA4 通过抑制 METTL3 促进 M2 巨噬细胞极化从而增强前列腺癌的进展。
Int Immunopharmacol. 2022 Jun;107:108586. doi: 10.1016/j.intimp.2022.108586. Epub 2022 Feb 25.
2
Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2-IRF pathway.脂氧素 A4 通过 FPR2-IRF 通路调节 M1/M2 巨噬细胞极化。
Inflammopharmacology. 2022 Apr;30(2):487-498. doi: 10.1007/s10787-022-00942-y. Epub 2022 Mar 2.
3
Mechanical stress protects against chondrocyte pyroptosis through lipoxin A via synovial macrophage M2 subtype polarization in an osteoarthritis model.机械应力通过滑膜巨噬细胞 M2 亚型极化脂氧素 A 保护软骨细胞免于细胞焦亡,从而在骨关节炎模型中发挥作用。
Biomed Pharmacother. 2022 Sep;153:113361. doi: 10.1016/j.biopha.2022.113361. Epub 2022 Jul 4.
4
In vitro phenotypic effects of Lipoxin A4 on M1 and M2 polarized macrophages derived from THP-1.脂氧素A4对源自THP-1的M1和M2极化巨噬细胞的体外表型效应。
Mol Biol Rep. 2023 Jan;50(1):339-348. doi: 10.1007/s11033-022-08041-5. Epub 2022 Nov 4.
5
Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.脂氧素 A4 对激活的鼠巨噬细胞电压依赖性和内向整流钾通道的调制:在先天免疫中的意义。
J Immunol. 2013 Dec 15;191(12):6136-46. doi: 10.4049/jimmunol.1300235. Epub 2013 Nov 18.
6
The -methyladenosine (mA)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of mRNA.甲基腺苷(mA)形成酶 METTL3 通过 m RNA 的甲基化促进 M1 巨噬细胞极化。
Am J Physiol Cell Physiol. 2019 Oct 1;317(4):C762-C775. doi: 10.1152/ajpcell.00212.2019. Epub 2019 Jul 31.
7
Lipoxin A4 redistributes myosin IIA and Cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytes.脂氧素A4在巨噬细胞中重新分布肌球蛋白IIA和Cdc42:对凋亡白细胞吞噬作用的影响。
J Immunol. 2006 Feb 1;176(3):1878-88. doi: 10.4049/jimmunol.176.3.1878.
8
Lipoxin A selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression.脂氧素A可选择性地塑造M2肿瘤相关巨噬细胞的特征,这些巨噬细胞有利于控制肿瘤进展。
Int J Cancer. 2017 Jan 15;140(2):346-357. doi: 10.1002/ijc.30424. Epub 2016 Oct 31.
9
The atheroprotective role of lipoxin A prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway.脂氧素 A 的抗动脉粥样硬化作用通过 JNK 通路防止 oxLDL 诱导的巨噬细胞凋亡信号。
Atherosclerosis. 2018 Nov;278:259-268. doi: 10.1016/j.atherosclerosis.2018.09.025. Epub 2018 Sep 28.
10
Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.脂氧素对人单核细胞和急性单核细胞白血病细胞系(THP-1)的激活涉及脂氧素A4与脂氧素B4的独特信号通路:钙动员差异的证据。
J Immunol. 1996 Sep 1;157(5):2149-54.

引用本文的文献

1
Lipoxins as Modulators of Diseases.脂氧素作为疾病的调节剂。
Cells. 2025 Aug 12;14(16):1244. doi: 10.3390/cells14161244.
2
Navigating the role of protein lactylation in prostate cancer and its implications for immunotherapy.探索蛋白质乳酰化在前列腺癌中的作用及其对免疫治疗的影响。
J Cancer. 2025 Jun 12;16(8):2706-2719. doi: 10.7150/jca.114137. eCollection 2025.
3
Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy.肿瘤相关巨噬细胞重塑抑制性肿瘤免疫微环境及免疫治疗的靶向治疗。
J Exp Clin Cancer Res. 2025 May 16;44(1):145. doi: 10.1186/s13046-025-03377-9.
4
METTL3: a multifunctional regulator in diseases.METTL3:疾病中的多功能调节因子
Mol Cell Biochem. 2025 Jan 24. doi: 10.1007/s11010-025-05208-z.
5
Decoding the role of tRNA modifications in cancer progression.解析 tRNA 修饰在癌症进展中的作用。
Curr Opin Genet Dev. 2024 Oct;88:102238. doi: 10.1016/j.gde.2024.102238. Epub 2024 Jul 31.
6
METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.METTL3 通过诱导 HOXC6 m6A 修饰并通过 IGF2BP2 依赖性机制稳定其表达促进前列腺癌进展。
Mol Cell Biochem. 2024 Jul;479(7):1707-1720. doi: 10.1007/s11010-024-05023-y. Epub 2024 May 31.
7
Role of N‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review).N6-甲基腺苷在前列腺癌发病机制、诊断和治疗中的作用(综述)。
Oncol Rep. 2024 Jun;51(6). doi: 10.3892/or.2024.8747. Epub 2024 May 17.
8
The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.泌尿系统肿瘤中非编码 RNA-分子靶点网络与 N6-甲基腺苷修饰的关系。
Cell Death Dis. 2024 Apr 17;15(4):275. doi: 10.1038/s41419-024-06664-z.
9
Targeting inflammation as cancer therapy.靶向炎症作为癌症治疗方法。
J Hematol Oncol. 2024 Mar 22;17(1):13. doi: 10.1186/s13045-024-01528-7.
10
mA methylation modification and immune cell infiltration: implications for targeting the catalytic subunit mA-METTL complex in gastrointestinal cancer immunotherapy.mA 甲基化修饰和免疫细胞浸润:靶向胃肠道癌症免疫治疗中催化亚基 mA-METTL 复合物的意义。
Front Immunol. 2023 Dec 15;14:1326031. doi: 10.3389/fimmu.2023.1326031. eCollection 2023.